|Articles|February 1, 2014
- BioPharm International-02-01-2014
- Volume 27
- Issue 2
BioPharm International, February 2014 Issue (PDF)
Click the title above to open the BioPharm International February 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 12 years ago
Novel Expression Systems Opening CMO Opportunitiesabout 12 years ago
EMA Collaborates with HTA Assessment Networksabout 12 years ago
Tackling the Challenge of HOS Determinationabout 12 years ago
The Affordable Care Act's Impact on Innovation in Biopharmaabout 12 years ago
Cytotoxicity Risks in Single-use Media and Bioreactor Containersabout 12 years ago
Defining Quality Metrics is No Easy TaskNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
